Casticin, a polymethoxyflavone, derived from natural plant Fructus Viticis exhibits biological activities including anti-
cancer characteristics. The anti-
cancer and alter gene expression of
casticin on human
colon cancer cells and the underlying mechanisms were investigated. Flow cytometric assay was used to measure viable cell, cell cycle and sub-G1 phase,
reactive oxygen species (ROS) and Ca2+ productions, level of mitochondria membrane potential (ΔΨm ) and
caspase activity. Western blotting assay was used to detect expression of
protein level associated with cell death.
Casticin induced cell morphological changes, decreased cell viability and induced G2/M phase arrest in colo 205 cells.
Casticin increased ROS production but decreased the levels of ΔΨm , and Ca2+ , increased
caspase-3, -8, and -9 activities. The
cDNA microarray indicated that some of the cell cycle associated genes were down-regulated such as
cyclin-dependent kinase inhibitor 1A (CDKN1A) (p21, Cip1) and p21
protein (Cdc42/Rac)-activated
kinase 3 (PAK3).
TNF receptor-associated protein 1 (TRAP1), CREB1 (cAMP responsive
element binding protein 1) and
cyclin-dependent kinase inhibitor 1B (CDKN1B) (p27, Kip1) genes were increased but matrix
metallopeptidase 2 (MMP-2),
toll-like receptor 4 (TLR4), PRKAR2B (
protein kinase, cAMP-dependent, regulatory, type II, bet), and CaMK4 (
calcium/calmodulin-dependent protein kinase IV) genes were inhibited. Results suggest that
casticin induced cell apoptosis via the activation of the
caspase- and/or mitochondria-dependent signaling cascade, the accumulation of ROS and altered associated gene expressions in colo 205 human
colon cancer cells.